Browsing by Author

Now showing items 1-1 of 1

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors

Le Tourneau, Christophe; Becker, Heiko; Claus, Rainer; Ricci, Francesco; Fritsch, R.; Elez, Elena; Tabernero, Josep (Elsevier, 2022-10)